Sort by

Send to

Choose Destination

Links from PubMed

Items: 14


Marijuana for Glaucoma: A Recipe for Disaster or Treatment?

Sun X, Xu CS, Chadha N, Chen A, Liu J.

Yale J Biol Med. 2015 Sep 3;88(3):265-9. eCollection 2015 Sep. Review.


Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity.

Pacek LR, Mauro PM, Martins SS.

Drug Alcohol Depend. 2015 Apr 1;149:232-44. doi: 10.1016/j.drugalcdep.2015.02.009. Epub 2015 Feb 17.


Pharmacotherapies for cannabis dependence.

Marshall K, Gowing L, Ali R, Le Foll B.

Cochrane Database Syst Rev. 2014;(12):CD008940. doi: 10.1002/14651858.CD008940.pub2. Epub 2014 Dec 17. Review.


Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions.

Khan SS, Secades-Villa R, Okuda M, Wang S, PĂ©rez-Fuentes G, Kerridge BT, Blanco C.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):101-8. doi: 10.1016/j.drugalcdep.2012.10.015. Epub 2012 Nov 22.


Identifying risk factors for marijuana use among veterans affairs patients.

Goldman M, Suh JJ, Lynch KG, Szucs R, Ross J, Xie H, O'Brien CP, Oslin DW.

J Addict Med. 2010 Mar;4(1):47-51. doi: 10.1097/ADM.0b013e3181b18782.


A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence.

Secora AM, Eddie D, Wyman BJ, Brooks DJ, Mariani JJ, Levin FR.

J Addict Dis. 2010 Jul;29(3):325-37. doi: 10.1080/10550887.2010.489444.


[Pharmacological and psychosocial interventions for cannabis use disorders].

Budney AJ, Vandrey RG, Stanger C.

Rev Bras Psiquiatr. 2010 May;32 Suppl 1:S46-55. Review. Portuguese.


Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency department.

Bernstein E, Edwards E, Dorfman D, Heeren T, Bliss C, Bernstein J.

Acad Emerg Med. 2009 Nov;16(11):1174-85. doi: 10.1111/j.1553-2712.2009.00490.x.


Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability.

Ehlers CL, Gizer IR, Vieten C, Gilder DA, Stouffer GM, Lau P, Wilhelmsen KC.

Addict Behav. 2010 Feb;35(2):102-10. doi: 10.1016/j.addbeh.2009.09.009. Epub 2009 Sep 19.


A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

Carpenter KM, McDowell D, Brooks DJ, Cheng WY, Levin FR.

Am J Addict. 2009 Jan-Feb;18(1):53-64. doi: 10.1080/10550490802408936.


Marijuana neurobiology and treatment.

Elkashef A, Vocci F, Huestis M, Haney M, Budney A, Gruber A, el-Guebaly N.

Subst Abus. 2008;29(3):17-29. doi: 10.1080/08897070802218166. Review.


Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome.

Aharonovich E, Brooks AC, Nunes EV, Hasin DS.

Drug Alcohol Depend. 2008 Jun 1;95(3):279-83. doi: 10.1016/j.drugalcdep.2008.01.009. Epub 2008 Mar 7.


Marijuana dependence and its treatment.

Budney AJ, Roffman R, Stephens RS, Walker D.

Addict Sci Clin Pract. 2007 Dec;4(1):4-16. Review.


Negative consequences associated with dependence in daily cannabis users.

Looby A, Earleywine M.

Subst Abuse Treat Prev Policy. 2007 Jan 10;2:3.

Items per page

Supplemental Content

Write to the Help Desk